"The Duke Child and Family Study Center is made up of several programs, including Duke Attention Deficit Hyperactivity Disorder (ADHD) Clinic, Duke Center for Eating Disorders, Duke ChildrenÄôs Evaluation Center, Duke Family Studies Program and Clinic, Duke Psychosocial Treatment Clinic, Duke Behavioral Interventions Program, Program in Child Affective and Anxiety Disorders (PCAAD), and Duke Center for Autism and Brain Development."

During the past decade, Duke Child and Family Study Center conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 10 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Duke Child and Family Study Center" #1 sponsor was "Duke University" with 14 trials, followed by "Shire" with 6 trials sponsored, "Sunovion" with 3 trials sponsored, "Akili Interactive Labs, Inc." with 2 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duke Child and Family Study Center" #1 collaborator was "National Institute of Mental Health (NIMH)" with 4 trials as a collaborator, "John Templeton Foundation" with 2 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator, "Otsuka America Pharmaceutical" with 2 trials as a collaborator and "UConn Health" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Duke Child and Family Study Center" are "ADHD" (5 trials), "Attention Deficit Hyperactivity Disorder" (4 trials), "Depression" (3 trials), "Adult Attention Deficit Hyperactivity Disorder" (2 trials) and "Attention Deficit Disorder With Hyperactivity" (2 trials). Many other conditions were trialed in "Duke Child and Family Study Center" in a lesser frequency.

Most popular intervention types in "Duke Child and Family Study Center" are "Drug" (17 trials), "Behavioral" (9 trials), "Other" (6 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Aripiprazole" (3 trials), "Dasotraline" (2 trials), "SPD489" (2 trials) and "AKL-T01" (1 trials). Other intervention names were less common.

The vast majority of trials in "Duke Child and Family Study Center" are 30 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Duke Child and Family Study Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Duke Child and Family Study Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Duke Child and Family Study Center, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".

Duke Child and Family Study Center has several departments that took part in Clinical trials: "Duke Comprehensive Cancer Center" - 589 trials, "Duke Cancer Institute Cary" - 12 trials, "Cancer Centers of North Carolina - Raleigh" - 9 trials, "Duke Children's Primary Care" - 7 trials, "Duke Cardiovascular Magnetic Resonance Center" - 4 trials, "Duke Cardiology at Southpoint" - 4 trials, "Regional Cancer Care" - 2 trials, "Regional Cancer Care PA" - 2 trials, "Pediatric Allergy and Immunology of Duke Medical Center" - 2 trials